EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray Donggen LiuJiehua HeTao Qin Original Paper 25 January 2011 Pages: 401 - 405
Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray Jiehua HeRoujun PengTao Qin Original Paper 25 January 2011 Pages: 406 - 410
Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters R. NaiduC. H. YipN. A. M. Taib Original Paper 08 February 2011 Pages: 411 - 417
Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients Si SunLei Ping WangBi Yun Wang Original Paper 06 February 2011 Pages: 418 - 424
DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy Xi-ru LiLiu-quan ChengLei Liu Original Paper 01 February 2011 Pages: 425 - 431
Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer Helene SvenssonThomas HatschekYvonne Brandberg Original Paper 06 February 2011 Pages: 432 - 438
Type 1 receptor parathyroid hormone (PTH1R) influences breast cancer cell proliferation and apoptosis induced by high levels of glucose Huasheng LiangYuhua ZhongGenben Chen Original Paper 11 February 2011 Pages: 439 - 445
Is there an association between human immunodeficiency virus infection and breast cancer? Hamid Salim ShaabanYashpal ModiGunwant Guron Letter to the Editor 17 February 2011 Pages: 446 - 447
Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells Tian-Song XiaJing-Ping ShiYong-Bin Ding Original Paper 24 February 2011 Pages: 448 - 453
Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC A. HalimH. Wahba Original Paper 25 February 2011 Pages: 454 - 458
Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis Pietro SanpaoloViviana BarbieriVincenzo Fusco Original Paper 26 February 2011 Pages: 459 - 465
HLA class-II allele frequencies in Turkish breast cancer patients Faik Deniz GunOzlem Goruroglu OzturkGurbuz Polat Original Paper 04 March 2011 Pages: 466 - 471
The TP53 gene polymorphisms and survival of sporadic breast cancer patients V. BišofM. Peričić SalihovićP. Rudan Original Paper 02 March 2011 Pages: 472 - 478
A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer Sheng ZhangChongjian ZhangJin Zhang Original Paper 06 March 2011 Pages: 479 - 485
Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer B. PetricevicD. VrbanecV. Bali Original Paper 13 March 2011 Pages: 486 - 494
ER−/ER+ breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection Wei YingSumeng WangYujie Sun Original Paper 12 March 2011 Pages: 495 - 502
Meta-analysis of concomitant compared to sequential adjuvant trastuzumab in breast cancer: the sooner the better Fausto PetrelliSandro Barni Short Communication 13 March 2011 Pages: 503 - 510
Killer cell immunoglobulin-like receptor genes in patients with breast cancer Ozlem Goruroglu OzturkFaik Deniz GunGurbuz Polat Original Paper 09 April 2011 Pages: 511 - 515
Polymorphic CA repeat length in insulin-like growth factor 1 and risk of breast cancer in Iranian women Morteza JavadiSimin HemattiManoochehr Tavassoli Original Paper 12 April 2011 Pages: 516 - 520
Absence of human papillomavirus in patients with breast cancer in north-west China Peng ChangTing WangJianghao Chen Original Paper 17 April 2011 Pages: 521 - 525
The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer Dabei TangShanqi XuWenhui Zhao Original Paper 26 April 2011 Pages: 526 - 533
Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein Yinxu ZhangXiaomei LiuJun Hua Zhang Original Paper 12 May 2011 Pages: 534 - 538
Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women L. C. SinghAnurupa ChakrabortySunita Saxena Original Paper 29 April 2011 Pages: 539 - 546
Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens Shusen WangYanxia ShiXiaomei Jiang Original Paper 29 April 2011 Pages: 547 - 553
Outcome of non-metastatic male breast cancer: 118 patients Ülkü Yalçıntaş ArslanBerna ÖksüzoğluAbdurrahman Işıkdoğan Original Paper 15 May 2011 Pages: 554 - 560
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients Irena RanogajecJasminka Jakić-RazumovićJelka Gabrilovac Original Paper 25 May 2011 Pages: 561 - 569
Smoking reduces survival in young females with lung adenocarcinoma after curative resection Ming LiuGening JiangNan Song Original Paper 30 January 2011 Pages: 570 - 573
The influence of intraoperative pleural perfusion with matrine–cisplatin or cisplatin on stromal cell-derived factor-1 in non-small cell lung cancer patients with subclinical pleural metastasis Cheng-liang YangShun-shou LiuBo Huang Original Paper 11 February 2011 Pages: 574 - 581
The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients Yoon Ji ChoiSeung Tae KimYeul Hong Kim Original Paper 16 February 2011 Pages: 582 - 588
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer Ozkan SaydamMertol GokceOzgur Tanriverdi Original Paper 06 March 2011 Pages: 589 - 594
Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancer Jing DengWei Jia FangLi Song Teng Original Paper 12 March 2011 Pages: 595 - 599
Concurrent and sequential administration of sunitinib malate and docetaxel in human non-small cell lung cancer cells and xenografts Dongchun WangZhenzhou JiangLuyong Zhang Original Paper 01 April 2011 Pages: 600 - 606
Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be? Ali KilicgunOzgur TanriverdiAtilla Gurses Original Paper 24 March 2011 Pages: 607 - 613
Amyloid-like fibrils are not detected in non-small cell lung cancer tissue samples Luiz Henrique de Lima AraújoLuciana W. PintoCinthya Sternberg Original Paper 26 March 2011 Pages: 614 - 617
High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer Xiao-Guang LiuWang-Yu ZhuYong-Kui Zhang Original Paper 24 April 2011 Pages: 618 - 626
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy She-Juan AnYi-Sheng HuangYi-Long Wu Original Paper 03 April 2011 Pages: 627 - 632
Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma Dong LiangYuZhi Shi Original Paper 12 April 2011 Pages: 633 - 639
Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients Dae Ho LeeChang-Min ChoiJung-Shin Lee Original Paper 16 April 2011 Pages: 640 - 643
Colonic metastasis from primary lung adenocarcinoma: case report and review of the literature Xing-Yang XueMing ZhouJian Zhao Case Report 24 April 2011 Pages: 644 - 647
Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas Ping ZhanXiao-kun ShenLi-Ke Yu Original Paper 26 April 2011 Pages: 648 - 655
Potential role of AQP1 and VEGF in the development of malignant pleural effusion in mice Jing Xuan ZhangC. M. XieZ. L. Zeng Original Paper 26 April 2011 Pages: 656 - 662
Expression of GPC3 protein and its significance in lung squamous cell carcinoma Qiang LinLi-wen XiongMing Chen Original Paper 10 May 2011 Pages: 663 - 669
Radiation-induced sarcoma of head and neck: 50 years of experience at a single institution in an endemic area of nasopharyngeal carcinoma in China Zhengbo WeiYing XieGuangwu Huang Original Paper 23 January 2011 Pages: 670 - 676
CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population Weijia LiuEnxin ZhuTingjiao Liu Original Paper 05 February 2011 Pages: 677 - 681
Association between Gly1619ARG polymorphism of IGF2R domain 11 (rs629849) and advanced stage of oral cancer Angela J. YoonAthanasios I. ZavrasShun-Fa Yang Original Paper 24 February 2011 Pages: 682 - 685
Phenytoin- and cranial radiotherapy-induced toxic epidermal necrolysis treated with combination therapy: systemic steroid and intravenous immunoglobulin E. FidanM. FidanF. Aydin Case Report 24 February 2011 Pages: 686 - 689
Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells Sittichai KoontongkaewPanomwat AmornphimolthamMontira Leelakriangsak Original Paper 06 March 2011 Pages: 690 - 703
Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review Orit Kaidar-PersonSalem BillanAbraham Kuten Case Report 06 March 2011 Pages: 704 - 706
The correlation between tumor-infiltrating Foxp3+ regulatory T cells and cyclooxygenase-2 expression and their association with recurrence in resected head and neck cancers Dian-shui SunMiao-qing ZhaoYu-hua Jiang Original Paper 22 March 2011 Pages: 707 - 713
Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells Xu-yuan LiYing-cheng LinWei-bing Li Original Paper 24 March 2011 Pages: 714 - 720
